The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests.
Read More
Siemens Healthineers’ Advia Centaur Interleukin-6 test can be used to determine the risk of mechanical ventilation for hospitalized covid-19 patients.
Read More
Use of pooled sampling with Enzo’s molecular diagnostic technology can help rapidly expand the number of people tested for covid-19.
Read More
The easy-to-use, visually read test could expand testing for covid-19 to diverse point-of-care locations.
Read More
Genscript’s test is capable of detecting virus-blocking antibodies that can be performed in standard labs in under an hour.
Read More